These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 28554769

  • 1. Immunohistochemical expression of p16, Ki-67 and p53 in cervical lesions - A systematic review.
    Silva DC, Gonçalves AK, Cobucci RN, Mendonça RC, Lima PH, Cavalcanti G.
    Pathol Res Pract; 2017 Jul; 213(7):723-729. PubMed ID: 28554769
    [Abstract] [Full Text] [Related]

  • 2. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
    Feng W, Xiao J, Zhang Z, Rosen DG, Brown RE, Liu J, Duan X.
    Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis.
    Sağlam A, Usubütün A, Dolgun A, Mutter GL, Salman MC, Kurtulan O, Akyol A, Özkan EA, Baykara S, Bülbül D, Calay Z, Eren F, Gümürdülü D, Haberal N, Ilvan Ş, Karaveli Ş, Koyuncuoğlu M, Müezzinoğlu B, Müftüoğlu KH, Özen Ö, Özdemir N, Peştereli E, Ulukuş Ç, Zekioğlu O.
    Turk Patoloji Derg; 2017 Sep; 1(1):177-191. PubMed ID: 28832077
    [Abstract] [Full Text] [Related]

  • 7. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
    Wu Y, Zhao J, Hu J, Wu XW, Zhu LR.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Nov 25; 52(11):734-739. PubMed ID: 29179267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Utility of Ki-67 and p53 in distinguishing cervical intraepithelial neoplasia 3 from squamous cell carcinoma of the cervix.
    Tan GC, Sharifah NA, Shiran MS, Salwati S, Hatta AZ, Paul-Ng HO.
    Asian Pac J Cancer Prev; 2008 Nov 25; 9(4):781-4. PubMed ID: 19256776
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT, Castle PE, Atkins KA, Brix WK, Nassau SR, Stoler MH.
    Am J Surg Pathol; 2010 Aug 25; 34(8):1077-87. PubMed ID: 20661011
    [Abstract] [Full Text] [Related]

  • 12. Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
    Umphress B, Sanchez B, Paintal A, Nayar R, Maniar KP.
    Am J Surg Pathol; 2018 Apr 25; 42(4):479-484. PubMed ID: 29438168
    [Abstract] [Full Text] [Related]

  • 13. Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer.
    Celewicz A, Celewicz M, Wężowska M, Chudecka-Głaz A, Menkiszak J, Urasińska E.
    Pol J Pathol; 2018 Apr 25; 69(1):42-47. PubMed ID: 29895125
    [Abstract] [Full Text] [Related]

  • 14. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL, Koh CC, Nazarina AR, Teoh KH, Looi LM.
    Malays J Pathol; 2016 Apr 25; 38(1):33-8. PubMed ID: 27126662
    [Abstract] [Full Text] [Related]

  • 15. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.
    Zhou WQ, Sheng QY, Sheng YH, Hou WJ, Xu GX, Wu YM, Lu H.
    Eur J Gynaecol Oncol; 2015 Apr 25; 36(1):62-8. PubMed ID: 25872337
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
    Focchi GR, Silva ID, Nogueira-de-Souza NC, Dobo C, Oshima CT, Stavale JN.
    J Low Genit Tract Dis; 2007 Apr 25; 11(2):98-104. PubMed ID: 17415114
    [Abstract] [Full Text] [Related]

  • 17. Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.
    Kanthiya K, Khunnarong J, Tangjitgamol S, Puripat N, Tanvanich S.
    Asian Pac J Cancer Prev; 2016 Apr 25; 17(7):3201-6. PubMed ID: 27509952
    [Abstract] [Full Text] [Related]

  • 18. p16 is superior to Stathmin-1 and HSP27 in identifying cervical dysplasia.
    Liou S, Nilforoushan N, Kang Y, Moatamed NA.
    Diagn Pathol; 2021 Sep 20; 16(1):85. PubMed ID: 34544445
    [Abstract] [Full Text] [Related]

  • 19. Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions.
    Maniar KP, Sanchez B, Paintal A, Gursel DB, Nayar R.
    Am J Surg Pathol; 2015 Dec 20; 39(12):1708-18. PubMed ID: 26371784
    [Abstract] [Full Text] [Related]

  • 20. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N.
    JAMA Oncol; 2019 Feb 01; 5(2):181-186. PubMed ID: 30325982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.